Exploratory Study Evaluating the Effects of Dermo-cosmetic RV5026B Applied for 2 Months in Adults With Erythrocouperosis

NCT06824870 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

28

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of recruitment

Conditions

Erythrocouperose Associated With Pityriasis Folliculorum of the Face

Interventions

OTHER: RV5026B - ET1732 - Period 1
DRUG: reference topical product - Period 2
OTHER: RV5026B - ET1732 - Period 2

Sponsor

Pierre Fabre Dermo Cosmetique